DZ Bank’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1M Sell
551,075
-16,040
-3% -$506K 0.02% 286
2026
Q1
$15.9M Buy
567,115
+107,981
+24% +$3.54M 0.01% 317
2025
Q4
$17.2M Buy
459,134
+193,419
+73% +$6.36M 0.01% 291
2025
Q3
$7.32M Buy
265,715
+261,913
+6,889% +$9.02M 0.01% 447
2025
Q2
$120K Buy
+3,802
New +$122K ﹤0.01% 859

Other funds holding HRMY

DZ Bank's HRMY Position: Q2 2026 in Review

DZ Bank reduced its Harmony Biosciences (HRMY) stake by 2.8% in Q2 2026, selling an estimated $506K and leaving 551,075 shares worth $20.1M. The position accounts for 0.02% of the portfolio, ranked #286.

DZ Bank first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • DZ Bank held 551,075 shares of Harmony Biosciences worth $20.1M as of Q2 2026.
  • DZ Bank sold 16,040 Harmony Biosciences shares in Q2 2026, an estimated $506K.
  • Harmony Biosciences made up 0.02% of DZ Bank's portfolio in Q2 2026, its #286 holding.
  • DZ Bank first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.